These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

141 related items for PubMed ID: 6254109

  • 1. The effects of viral infections on renal transplants and their recipients.
    Warrell MJ, Chinn I, Morris PJ, Tobin JO.
    Q J Med; 1980; 49(194):219-31. PubMed ID: 6254109
    [Abstract] [Full Text] [Related]

  • 2. [Serologic follow-up of cytomegalovirus, herpes simplex and varicella-zoster infections in kidney transplant recipients].
    Merlino C.
    G Batteriol Virol Immunol; 1991; 84(1-12):41-52. PubMed ID: 1668971
    [Abstract] [Full Text] [Related]

  • 3. The transplanted kidney as a source of cytomegalovirus infection.
    Ho M, Suwansirikul S, Dowling JN, Youngblood LA, Armstrong JA.
    N Engl J Med; 1975 Nov 27; 293(22):1109-12. PubMed ID: 171567
    [Abstract] [Full Text] [Related]

  • 4. [Risk of CMV infection and illness after kidney transplantation].
    Kaden J, Zenker S, Eichler C, Groth J, May G, Strobelt V, Oesterwitz H, Scholz D, Lippert J, Adamczyk G.
    Allerg Immunol (Leipz); 1991 Nov 27; 37(1):47-58. PubMed ID: 1648299
    [Abstract] [Full Text] [Related]

  • 5. Cytomegalo and herpes simplex virus infections in renal transplant recipients.
    Wertheim P, Slaterus KW, Geelen JL, van der Noordaa J, Wilmink JM.
    Scand J Urol Nephrol Suppl; 1985 Nov 27; 92():5-8. PubMed ID: 3008317
    [Abstract] [Full Text] [Related]

  • 6. Efficacy of oral ganciclovir in prevention of cytomegalovirus infection in post-kidney transplant patients.
    Ahsan N, Holman MJ, Yang HC.
    Clin Transplant; 1997 Dec 27; 11(6):633-9. PubMed ID: 9408699
    [Abstract] [Full Text] [Related]

  • 7. CMV hepatitis after liver transplantation: incidence, clinical course, and long-term follow-up.
    Seehofer D, Rayes N, Tullius SG, Schmidt CA, Neumann UP, Radke C, Settmacher U, Müller AR, Steinmüller T, Neuhaus P.
    Liver Transpl; 2002 Dec 27; 8(12):1138-46. PubMed ID: 12474153
    [Abstract] [Full Text] [Related]

  • 8. Transplanting kidneys from CMV-seropositive donors to CMV-seronegative recipients is not associated with poorer renal allograft function or survival.
    McLaughlin K, Sandhu S, Wu C, Muirhead N, Hollomby D, Jevnikar A.
    Nephrol Dial Transplant; 2005 Jan 27; 20(1):176-80. PubMed ID: 15572381
    [Abstract] [Full Text] [Related]

  • 9. Association of the outcome of renal transplantation with antibody response to cytomegalovirus strain-specific glycoprotein H epitopes.
    Ishibashi K, Tokumoto T, Tanabe K, Shirakawa H, Hashimoto K, Kushida N, Yanagida T, Inoue N, Yamaguchi O, Toma H, Suzutani T.
    Clin Infect Dis; 2007 Jul 01; 45(1):60-7. PubMed ID: 17554702
    [Abstract] [Full Text] [Related]

  • 10. Risk factors for cytomegalovirus, hepatitis B and C virus reactivation after bone marrow transplantation.
    Zekri AR, Mohamed WS, Samra MA, Sherif GM, El-Shehaby AM, El-Sayed MH.
    Transpl Immunol; 2004 Dec 01; 13(4):305-11. PubMed ID: 15589744
    [Abstract] [Full Text] [Related]

  • 11. Effect of primary and recurrent cytomegalovirus infections upon graft and patient survival after renal transplantation.
    Whelchel JD, Pass RF, Diethelm AG, Whitley RJ, Alford CA.
    Transplantation; 1979 Dec 01; 28(6):443-6. PubMed ID: 229592
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Infectious complications in kidney transplant recipients: a single-center experience.
    Charfeddine K, Zaghden S, Kharrat M, Kamoun K, Jarraya F, Hachicha J.
    Transplant Proc; 2005 Dec 01; 37(6):2823-5. PubMed ID: 16182820
    [Abstract] [Full Text] [Related]

  • 15. Prospective study of the prevalence and symptomatology of cytomegalovirus infection in renal transplant recipients.
    Chatterjee SN, Jordan GW.
    Transplantation; 1979 Dec 01; 28(6):457-60. PubMed ID: 229594
    [Abstract] [Full Text] [Related]

  • 16. Seroprevalence, incidence of prenatal infections and reliability of maternal history of varicella zoster virus, cytomegalovirus, herpes simplex virus and parvovirus B19 infection in South-Western Finland.
    Alanen A, Kahala K, Vahlberg T, Koskela P, Vainionpää R.
    BJOG; 2005 Jan 01; 112(1):50-6. PubMed ID: 15663397
    [Abstract] [Full Text] [Related]

  • 17. Acute rejection episodes in pediatric renal transplant recipients with cytomegalovirus infection.
    Kranz B, Vester U, Wingen AM, Nadalin S, Paul A, Broelsch CE, Hoyer PF.
    Pediatr Transplant; 2008 Jun 01; 12(4):474-8. PubMed ID: 18466436
    [Abstract] [Full Text] [Related]

  • 18. Cytomegalovirus antibody avidity in allogeneic bone marrow recipients: evidence for primary or secondary humoral responses depending on donor immune status.
    Lutz E, Ward KN, Szydlo R, Goldman JM.
    J Med Virol; 1996 May 01; 49(1):61-5. PubMed ID: 8732861
    [Abstract] [Full Text] [Related]

  • 19. [Evaluation of viral load and antigenemia as markers for relapse cytomegalovirus infection in renal transplant recipients].
    Franco A, Serrano R, Gimeno A, de Juan J, Merino E, Jiménez del Cerro L, Olivares J.
    Nefrologia; 2007 May 01; 27(2):202-8. PubMed ID: 17564566
    [Abstract] [Full Text] [Related]

  • 20. Incidence of cytomegalovirus-infection after renal transplantation and first experiences with prophylactic hyperimmunoglobulin.
    Fassbinder W, Bechstein PB, Scheuermann EH, Schoeppe W.
    Scand J Urol Nephrol Suppl; 1985 May 01; 92():23-8. PubMed ID: 3008313
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.